Samsung Pharma receives US$3.8m order for anti-hangover products

12:16
Job creation lowest on record among under-30s
11:31
[From the Scene] Immersive heritage exhibition opens in Gangneung, Las Vegas
10:51
Opposition leader faces sentencing hearing over allegedly suborning perjury this week
10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms

Samsung Pharma receives US$3.8m order for anti-hangover products

July 1, 2016 - 10:00 By 황유미

[DISCLOSURE] Samsung Pharmaceutical (001360) has signed a 4.4 billion won (US$3.8 million) contract with PICO Entech to supply anti-hangover products, it announced on July 1. This amounts to 10.44 percent of its recent revenue.

황유미